BG108538A - Нови индолови производни - Google Patents

Нови индолови производни Download PDF

Info

Publication number
BG108538A
BG108538A BG108538A BG10853804A BG108538A BG 108538 A BG108538 A BG 108538A BG 108538 A BG108538 A BG 108538A BG 10853804 A BG10853804 A BG 10853804A BG 108538 A BG108538 A BG 108538A
Authority
BG
Bulgaria
Prior art keywords
indol
piperazin
ethylsulfanyl
alkyl
compound
Prior art date
Application number
BG108538A
Other languages
Bulgarian (bg)
English (en)
Inventor
Mario Rottlaender
Ejner Moltzen
Ivan Mikkelsen
Thomas Ruhland
Kim Andersen
Christian Krog-Jensen
Original Assignee
H.Lundbeck A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H.Lundbeck A/S filed Critical H.Lundbeck A/S
Publication of BG108538A publication Critical patent/BG108538A/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
BG108538A 2001-06-29 2004-01-21 Нови индолови производни BG108538A (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA200101037 2001-06-29

Publications (1)

Publication Number Publication Date
BG108538A true BG108538A (bg) 2005-01-31

Family

ID=8160599

Family Applications (1)

Application Number Title Priority Date Filing Date
BG108538A BG108538A (bg) 2001-06-29 2004-01-21 Нови индолови производни

Country Status (28)

Country Link
US (1) US7342015B2 (fr)
EP (1) EP1399434B1 (fr)
JP (1) JP2004535448A (fr)
KR (1) KR20040019027A (fr)
CN (1) CN100338058C (fr)
AR (1) AR034658A1 (fr)
AT (1) ATE304007T1 (fr)
AU (1) AU2002344950B2 (fr)
BG (1) BG108538A (fr)
BR (1) BR0210407A (fr)
CA (1) CA2451229C (fr)
CZ (1) CZ2004155A3 (fr)
DE (1) DE60206043T2 (fr)
DK (1) DK1399434T3 (fr)
EA (1) EA006104B1 (fr)
ES (1) ES2247347T3 (fr)
HK (1) HK1069579A1 (fr)
HU (1) HUP0400834A2 (fr)
IL (1) IL158830A0 (fr)
IS (1) IS2431B (fr)
MX (1) MXPA03011766A (fr)
NO (1) NO326513B1 (fr)
NZ (1) NZ529461A (fr)
PL (1) PL366520A1 (fr)
SK (1) SK642004A3 (fr)
UA (1) UA74651C2 (fr)
WO (1) WO2003002552A1 (fr)
ZA (1) ZA200308848B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2451228A1 (fr) * 2001-06-29 2003-01-09 H. Lundbeck A/S Nouveaux derives heteroaryle, preparation et utilisation de ceux-ci
WO2006056600A1 (fr) 2004-11-26 2006-06-01 Janssen Pharmaceutica N.V. Derives d'isoxazoline-indole avec effet antipsychotique et anxiolytique ameliore
TWI329641B (en) * 2005-08-31 2010-09-01 Otsuka Pharma Co Ltd (benzo[b]thiophen-4-yl)piperazine compounds, pharmaceutical compositions comprising the same, uses of the same and processes for preparing the same
JP4785881B2 (ja) * 2007-02-27 2011-10-05 大塚製薬株式会社 医薬

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0900792B1 (fr) * 1997-09-02 2003-10-29 Duphar International Research B.V Dérivés de pipéridine et de pipérazine comme agonistes du récepteur 5-HT1
CN1155567C (zh) * 1998-04-29 2004-06-30 惠氏公司 抑制精神的吲哚基衍生物
AR027134A1 (es) * 1999-12-30 2003-03-12 Lundbeck & Co As H Derivados de indol.
CA2451228A1 (fr) 2001-06-29 2003-01-09 H. Lundbeck A/S Nouveaux derives heteroaryle, preparation et utilisation de ceux-ci

Also Published As

Publication number Publication date
ZA200308848B (en) 2006-02-22
DE60206043T2 (de) 2006-06-29
CZ2004155A3 (cs) 2004-07-14
UA74651C2 (en) 2006-01-16
WO2003002552A1 (fr) 2003-01-09
EA006104B1 (ru) 2005-08-25
JP2004535448A (ja) 2004-11-25
NO20035672D0 (no) 2003-12-18
CN100338058C (zh) 2007-09-19
DK1399434T3 (da) 2005-12-12
EP1399434A1 (fr) 2004-03-24
IS7022A (is) 2003-11-10
ES2247347T3 (es) 2006-03-01
US20060258678A1 (en) 2006-11-16
ATE304007T1 (de) 2005-09-15
US7342015B2 (en) 2008-03-11
NO20035672L (no) 2003-12-18
NZ529461A (en) 2005-09-30
HK1069579A1 (en) 2005-05-27
EA200400104A1 (ru) 2004-04-29
IL158830A0 (en) 2004-05-12
CA2451229A1 (fr) 2003-01-09
BR0210407A (pt) 2004-08-17
IS2431B (is) 2008-10-15
DE60206043D1 (de) 2005-10-13
AU2002344950B2 (en) 2008-04-03
MXPA03011766A (es) 2004-04-02
KR20040019027A (ko) 2004-03-04
PL366520A1 (en) 2005-02-07
HUP0400834A2 (hu) 2004-08-30
CA2451229C (fr) 2009-02-10
EP1399434B1 (fr) 2005-09-07
AR034658A1 (es) 2004-03-03
CN1529703A (zh) 2004-09-15
SK642004A3 (en) 2004-05-04
NO326513B1 (no) 2008-12-22

Similar Documents

Publication Publication Date Title
JP5132649B2 (ja) スルホンアミド誘導体類と、その製造方法及び医薬としての応用
US7393845B2 (en) Heteroaryl derivates, their preparation and use
US8623887B2 (en) Compounds
SK141998A3 (en) Piperidines and pyrrolidines
AU2002344949A1 (en) Novel heteroaryl derivatives, their preparation and use
BG108538A (bg) Нови индолови производни
SK9452002A3 (en) Indole derivatives, pharmaceutical composition containing the same and their use
US20070173522A1 (en) 4-(2-Phenylsulfanyl-phenyl)-1,2,3,6- tetrahydropyridine derivatives as serotonin reuptake inhibitors
AU2002344950A1 (en) Novel indole derivatives
KR20120101068A (ko) 신규 (헤테로사이클/테트라히드로피리딘)-(피페라지닐)-1-알카논 및 (헤테로사이클/디히드로피롤리딘)-(피페라지닐)-1-알카논유도체, 및 ｐ75 억제제로서의 그의 용도
SK402003A3 (en) Indole derivatives, pharmaceutical composition comprising same and their use